Related Experiment Video
Updated: May 19, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene
12011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Key Laboratory of Medical Epigenetics, Tianjin Medical University, Tianjin, China. chenghaoxuan@bjmu.edu.cn
Abstract:
The p53 tumor suppressor is important in many aspects of cell biology. Tight regulation of p53 is thus imperative for maintaining cell homeostasis and preventing tumorigenesis. The stabilization and activity of p53 is primarily regulated by MDM2, which is encoded for by HDM2. However, how the expression and activity of MDM2 is regulated remains largely unknown. Here, we report a novel BTB and BEN domains-containing protein, RBB. We demonstrated that RBB is a novel transcriptional repressor binding specific DNA motif via a homodimer and interacting with the nucleosome remodeling and deacetylase (NuRD) complex. Genome wide transcription target analysis by ChIP sequencing revealed that RBB represses the transcription of a series of functionally important genes including HDM2. We showed that RBB recruits the NuRD complex to the internal promoter of HDM2 and inhibits the expression of MDM2 protein, leading to subsequent stabilization of tumor suppressor p53. Significantly, we showed that RBB suppresses cell proliferation and sensitizes cells to DNA damage-induced apoptosis. Our data indicate that RBB is a novel transcriptional repressor and an important regulator of p53 pathway.
Insights
Researchers discovered RBB, a novel protein that acts as a transcriptional repressor. RBB regulates the p53 pathway by inhibiting HDM2 expression, thereby stabilizing tumor suppressor p53 and suppressing cell proliferation.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The p53 tumor suppressor is crucial for cell homeostasis and cancer prevention.
- MDM2 protein regulates p53 stability and activity, but MDM2 regulation is not fully understood.
Purpose of the Study:
- To identify novel regulators of the p53 pathway.
- To investigate the function of the newly identified RBB protein.
Main Methods:
- ChIP sequencing for genome-wide transcription target analysis.
- Co-immunoprecipitation to study protein interactions.
- Western blotting to assess protein levels.
Main Results:
- RBB identified as a novel transcriptional repressor that binds DNA via homodimerization.
- RBB interacts with the NuRD complex and recruits it to the HDM2 promoter.
- RBB represses HDM2 expression, leading to p53 stabilization.
- RBB suppresses cell proliferation and enhances apoptosis.
Conclusions:
- RBB is a novel regulator of the p53 pathway.
- RBB functions as a transcriptional repressor by recruiting the NuRD complex.
- RBB's role in p53 regulation suggests potential therapeutic implications in cancer.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Co-activators and Co-repressors
Master Transcription Regulators

